MCKECHNIE DUNCAN

PrivateCIK: 2062139
Location

BOSTON, MA

Senior insider sale

EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction

$2.39M

4.91K shares

What this filing means

MCKECHNIE DUNCAN plans to sell 4.91K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderMCKECHNIE DUNCANCIK 2062139
Officer· EVP, Chief Commercial Officer
Since Mar 2026
4.91K
Shares to sell
$2.39M
Approx. market value
4.91K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months11
Sort

ESPP Purchase

Cash

5/14/2025
46.00

Restricted Stock Vesting

Compensation

2/26/2025
994.00

Restricted Stock Vesting

Compensation

2/24/2025
331.00

Restricted Stock Vesting

Compensation

2/17/2025
1.22K

Restricted Stock Vesting

Compensation

2/10/2025
2.02K

ESPP Purchase

Cash

11/14/2024
18.00

ESPP Purchase

Cash

5/14/2024
52.00

ESPP Purchase

Cash

11/14/2023
23.00

ESPP Purchase

Cash

5/14/2023
59.00

ESPP Purchase

Cash

11/14/2022
57.00

ESPP Purchase

Cash

5/14/2022
89.00
Total acquired4.91K
Planned & Completed Dispositions1
Sort
NASDAQPlanned

Units to sell

4.91K

Market value

$2.39M

2/25/2026
Total

Units

4.91K

Value

$2.39M

MCKECHNIE DUNCAN — Planned Insider Sale (Form 144) | Finecho